BIO-IT World: Pharma IT Reviews
Technology Trends and Strategies for the Pharmaceutical Industry
20 May 2005
Making Pharma-Biotech Deals Work
Deals are the lifeblood - the engine - of the bioscience industry. Big pharma needs new compounds to fill its pipeline, while in capital-starved times, biotech needs licenses (to get license deals) to survive.
But what happens once the ink is dry on a deal? How do you ensure that technology is transferred, that projects progress as planned - that collaboration between what are often very different corporate animals is real?
The whole issue of improving the quality of collaboration in biosciences is fast becoming a senior management priority - and it is not hard to see why.
